Jupicid DSR 30mg/40mg Capsule is a combination pharmaceutical formulation containing Domperidone 30mg and Esomeprazole 40mg, designed to manage gastrointestinal disorders characterized by acid reflux and delayed gastric emptying. Domperidone, a peripheral dopamine D2 receptor antagonist, enhances gastrointestinal motility by increasing the movement of the stomach and intestines, thereby facilitating gastric emptying and reducing symptoms such as nausea, vomiting, and bloating. Esomeprazole, a proton pump inhibitor, suppresses gastric acid secretion by irreversibly inhibiting the H+/K+ ATPase enzyme system in the gastric parietal cells, effectively reducing gastric acidity and promoting mucosal healing in conditions like gastroesophageal reflux disease (GERD), erosive esophagitis, and peptic ulcer disease. The combined action of these agents provides symptomatic relief from heartburn, acid regurgitation, and dyspepsia while improving gastric motility. Jupicid DSR is indicated for the treatment of GERD with associated motility disorders and is typically administered orally once daily before meals. Caution is advised in patients with known hypersensitivity to either component, significant hepatic or renal impairment, and those on medications that may interact with domperidone or esomeprazole. Consultation with a healthcare professional is essential prior to initiation to ensure appropriate use and monitoring.